BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10827262)

  • 1. Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening systems.
    Beld M; Habibuw MR; Rebers SP; Boom R; Reesink HW
    Transfusion; 2000 May; 40(5):575-9. PubMed ID: 10827262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of automated nucleic acid extraction devices for application in HCV NAT.
    Jongerius JM; Bovenhorst M; van der Poel CL; van Hilten JA; Kroes AC; van der Does JA; van Leeuwen EF; Schuurman R
    Transfusion; 2000 Jul; 40(7):871-4. PubMed ID: 10924618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European multi-centre validation study of NucliSens Extractor in combination with HCV Amplicor 2.0 assay for HCV-NAT screening of plasma pools.
    Cuypers HT; van Dijk R; Viret JF; Schottstedt V; Lankinen M; Da Silva Cardoso M; Lelie PN
    Biologicals; 1999 Dec; 27(4):303-14. PubMed ID: 10686057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the NucliSens Extractor in combination with the hepatitis C virus Cobas Amplicor 2.0 assay in four laboratories in the Netherlands utilizing nucleic acid amplification technology for blood screening.
    Cuijpers HT; Molijn MH; Bos HJ; Peeters AP; van der Poel CL; Lelie PN
    Vox Sang; 2001 Jul; 81(1):12-20. PubMed ID: 11520410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of HCV RNA and HIV RNA blood screening assays.
    Lelie PN; van Drimmelen HA; Cuypers HT; Best SJ; Stramer SL; Hyland C; Allain JP; Moncharmont P; Defer C; Nübling M; Glauser A; da Silva Cardoso M; Viret JF; Lankinen MH; Grillner L; Wirthmüller U; Coste J; Schottstedt V; Masecar B; Dax EM
    Transfusion; 2002 May; 42(5):527-36. PubMed ID: 12084160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
    Koppelman MH; Sjerps MC; Reesink HW; Cuypers HT
    Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
    Jongerius JM; Sjerps M; Cuijpers HT; van Drimmelen HA; van der Poel CL; Reesink HW; Molijn MH; Peeters GA; Peeters TP; Lelie PN
    Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel RT-PCR for reliable and rapid HCV RNA screening of blood donations.
    Hennig H; Luhm J; Hartwig D; Klüter H; Kirchner H
    Transfusion; 2001 Sep; 41(9):1100-6. PubMed ID: 11552065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of blood donations by hepatitis C virus polymerase chain reaction (HCV-PCR) improves safety of blood products by window period reduction.
    Hitzler WE; Runkel S
    Clin Lab; 2001; 47(5-6):219-22. PubMed ID: 11405599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International collaborative study on the second EUROHEP HCV-RNA reference panel.
    Damen M; Cuypers HT; Zaaijer HL; Reesink HW; Schaasberg WP; Gerlich WH; Niesters HG; Lelie PN
    J Virol Methods; 1996 Apr; 58(1-2):175-85. PubMed ID: 8783163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new NASBA assay for the qualitative detection of hepatitis C virus based on the NucliSens Basic Kit reagents.
    Guichón A; Chiparelli H; Martínez A; Rodríguez C; Trento A; Russi JC; Carballal G
    J Clin Virol; 2004 Feb; 29(2):84-91. PubMed ID: 14747025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
    Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
    Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated screening of blood donations for hepatitis C virus RNA using the Qiagen BioRobot 9604 and the Roche COBAS HCV Amplicor assay.
    Grant PR; Sims CM; Krieg-Schneider F; Love EM; Eglin R; Tedder RS
    Vox Sang; 2002 May; 82(4):169-76. PubMed ID: 12047510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system.
    Sizmann D; Boeck C; Boelter J; Fischer D; Miethke M; Nicolaus S; Zadak M; Babiel R
    J Clin Virol; 2007 Apr; 38(4):326-33. PubMed ID: 17344093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
    Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
    Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV screening in blood donations using RT-PCR in mini-pool: the experience in Spain after routine use for 2 years.
    Eiras A; Sauleda S; Planelles D; Sedeño M; Ibarra A; Vesga MA; Franco E; Montoro JA; Hernández JM; Villaescusa RG
    Transfusion; 2003 Jun; 43(6):713-20. PubMed ID: 12757521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.
    Palomäki P; Wessberg S; Tuomi K; Laitinen H
    Transfusion; 2005 Sep; 45(9):1518-22. PubMed ID: 16131386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the MagNA pure LC instrument for extraction of hepatitis C virus RNA for the COBAS AMPLICOR Hepatitis C Virus Test, version 2.0.
    Germer JJ; Lins MM; Jensen ME; Harmsen WS; Ilstrup DM; Mitchell PS; Cockerill FR; Patel R
    J Clin Microbiol; 2003 Aug; 41(8):3503-8. PubMed ID: 12904346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment.
    Hourfar MK; Schmidt M; Seifried E; Roth WK
    Vox Sang; 2005 Aug; 89(2):71-6. PubMed ID: 16101686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.